RealMove (Lung): Assessing Tumour Motion With Dynamic MRI

The study aims to develop an improved method to tailor the geometric safety margin when treating with stereotactic body radiotherapy (SBRT), to avoid tumour cells being missed during irradiation and to limit the exposure of normal tissues as much as possible. Dynamic magnetic resonance imaging (MRI) is assumed to represent the tumour motion during the respiratory cycle more realistically, compared to 4-dimensional computed tomography (4D CT), thanks to its high temporal resolution and the possibility to image the motion over a longer period of time. Patients receiving SBRT for a pulmonary targ

Trial Details

NCT ID
NCT06322329
Phase
NA
Sponsor
Region Stockholm
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Dynamic MRI
Locations (sample)
  • Stockholm, Sweden|59.32938,18.06871

Key Eligibility Criteria

  • Accepted for SBRT treatment of one or more caudally situated lung targets (NSCLC or metastases), i.e. below the carina.
  • Age ≥ 18 years
  • Adequate clinical condition to maintain immobilised position for at least 30 minutes
  • Adequate Swedish skills and cognitive function to understand study information and to fill in the questionnaire

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →